234 related articles for article (PubMed ID: 31343458)
1. Prisons: ignore them at our peril.
Kamarulzaman A; Verster A; Altice FL
Curr Opin HIV AIDS; 2019 Sep; 14(5):415-422. PubMed ID: 31343458
[TBL] [Abstract][Full Text] [Related]
2. The Global State of Harm Reduction in Prisons.
Sander G; Shirley-Beavan S; Stone K
J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
[TBL] [Abstract][Full Text] [Related]
3. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P
Lancet; 2016 Sep; 388(10050):1228-48. PubMed ID: 27427455
[TBL] [Abstract][Full Text] [Related]
4. A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment.
Vagenas P; Azbel L; Polonsky M; Kerimi N; Mamyrov M; Dvoryak S; Altice FL
Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S25-31. PubMed ID: 23932844
[TBL] [Abstract][Full Text] [Related]
5. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
[TBL] [Abstract][Full Text] [Related]
6. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
Kamarulzaman A; Reid SE; Schwitters A; Wiessing L; El-Bassel N; Dolan K; Moazen B; Wirtz AL; Verster A; Altice FL
Lancet; 2016 Sep; 388(10049):1115-1126. PubMed ID: 27427456
[TBL] [Abstract][Full Text] [Related]
7. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
[TBL] [Abstract][Full Text] [Related]
8. Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.
Stöver H; Meroueh F; Marco A; Keppler K; Saiz de la Hoya P; Littlewood R; Wright N; Nava F; Alam F; Walcher S; Somaini L
BMC Public Health; 2019 Jan; 19(1):30. PubMed ID: 30621658
[TBL] [Abstract][Full Text] [Related]
9. Prisoners who inject drugs: public health and human rights imperatives.
Jürgens R; Betteridge G
Health Hum Rights; 2005; 8(2):46-74. PubMed ID: 17136903
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
[TBL] [Abstract][Full Text] [Related]
11. People who inject drugs in prison: HIV prevalence, transmission and prevention.
Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
[TBL] [Abstract][Full Text] [Related]
12. Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia.
Bick J; Culbert G; Al-Darraji HA; Koh C; Pillai V; Kamarulzaman A; Altice F
Int J Prison Health; 2016 Dec; 12(4):253-269. PubMed ID: 27921633
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C in European prisons: a call for an evidence-informed response.
Arain A; Robaeys G; Stöver H
BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S17. PubMed ID: 25252822
[TBL] [Abstract][Full Text] [Related]
14. HIV in prison in low-income and middle-income countries.
Dolan K; Kite B; Black E; Aceijas C; Stimson GV;
Lancet Infect Dis; 2007 Jan; 7(1):32-41. PubMed ID: 17182342
[TBL] [Abstract][Full Text] [Related]
15. Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.
Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N;
Int J Drug Policy; 2024 Apr; 126():104386. PubMed ID: 38492433
[TBL] [Abstract][Full Text] [Related]
16. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
Chakrapani V; Kamei R; Kipgen H; Kh JK
Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
[TBL] [Abstract][Full Text] [Related]
17. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.
Stark K; Herrmann U; Ehrhardt S; Bienzle U
Epidemiol Infect; 2006 Aug; 134(4):814-9. PubMed ID: 16371183
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of HIV risk and outcomes in a nationally representative sample of incarcerated women in Azerbaijan, Kyrgyzstan, and Ukraine.
Ranjit YS; Azbel L; Krishnan A; Altice FL; Meyer JP
AIDS Care; 2019 Jul; 31(7):793-797. PubMed ID: 30701981
[TBL] [Abstract][Full Text] [Related]
19. Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan.
Azbel L; Wickersham JA; Wegman MP; Polonsky M; Suleymanov M; Ismayilov R; Dvoryak S; Rotberga S; Altice FL
Drug Alcohol Depend; 2015 Jun; 151():68-75. PubMed ID: 25861943
[TBL] [Abstract][Full Text] [Related]
20. Overview of harm reduction in prisons in seven European countries.
Sander G; Scandurra A; Kamenska A; MacNamara C; Kalpaki C; Bessa CF; Laso GN; Parisi G; Varley L; Wolny M; Moudatsou M; Pontes NH; Mannix-McNamara P; Libianchi S; Antypas T
Harm Reduct J; 2016 Oct; 13(1):28. PubMed ID: 27717368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]